Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to evaluate the safety and effectiveness of the experimental drug PTX-022 in the treatment of angiokeratomas
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Open label | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| PTX-022 | Drug | topical administration of PTX-022 |
|
| Measure | Description | Time Frame |
|---|---|---|
| Incidence of Treatment-Emergent Adverse Events | 3 months | |
| Overall Angiokeratoma Investigator Global Assessment (AK-IGA) | 3 months | |
| Overall Patient Global Impression of Change (PGI-C) | 3 months |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Emily Cook | Contact | 267-738-6366 | emily.cook@palvellatx.com |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Unified Health | Not yet recruiting | Sherman Oaks | California | 91403 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Cleaver Medical Group | Recruiting | Dawsonville | Georgia | 30534 | United States |
|
| Vividia Dermatology | Not yet recruiting | Las Vegas | Nevada | 89148 | United States |
|
| Epiphany Dermatology | Recruiting | Southlake | Texas | 76092 | United States |
|
| ID | Term |
|---|---|
| D000794 | Angiokeratoma |
| ID | Term |
|---|---|
| D009383 | Neoplasms, Vascular Tissue |
| D009370 | Neoplasms by Histologic Type |
| D009369 | Neoplasms |
Not provided
Not provided